Combination Chemotherapy in Generalized Hodgkin's Disease
نویسندگان
چکیده
منابع مشابه
Combination chemotherapy in generalized Hodgkin's disease.
Fifty-two patients with generalized Hodgkin's disease were treated with a combination of mustine hydrochloride, vinblastine, procarbazine, and prednisolone. Complete remissions were obtained initially in six out of seven patients (86%) who had previously received no treatment, in 15 out of 19 (79%) who had had only radiotherapy in the past, and in 9 out of 26 (35%) who had previously been given...
متن کاملGonadal function after combination chemotherapy for Hodgkin's disease in childhood.
The effect of quadruple chemotherapy (mustine, vincristine, procarbazine, and prednisolone) on gonadal function was investigated in 15 males and 2 females treated for Hodgkin's disease during childhood. The 2 females have regular menstrual cycles with evidence of ovulation in one. Twelve of the males have shown normal progression of pubertal development since completing their treatment. Nine ou...
متن کاملIntensive Combination Chemotherapy and X-Irradiation in Hodgkin's Disease.
See related article by Moxley et al., Cancer Res 1967;27:1258–63. This article was a pilot study of the first attempt to cure an advanced solid tumor, in this case Hodgkin disease, with combination chemotherapy (1). It was very controversial. Virtually no one at the time believed it was possible to cure cancer with drugs. Furthermore, it was a general tenet ofmedicine then that drugs, for any d...
متن کاملViral-related RNA in Hodgkins' disease and other human lymphomas.
Molecular hybridization with radioactively labeled DNA complementary to the RNA of the Rauscher leukemia virus was used to probe for homologous RNA in human lymphomas. 22 of 32 specimens contained RNA possessing homology to the RNA of the mouse leukemia virus, but not to that of the unrelated viruses causing mammary tumors in mice or myeloblastosis in chickens. Normal adult and fetal tissues fa...
متن کاملCurrent strategies in the treatment of childhood Hodgkins disease.
Dramatic changes in the treatment of childhood Hodgkins disease have taken place during the past three decades. Contemporary combined modality treatment regimens produce durable disease-free survival in 90 to 100%of patients with early disease and in 70 to 85%of patients with advanced disease. Studies using chemotherapy alone also report high survival rates, and current studies are few to highl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1970
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.3.5713.7